POSITIVE OUTCOMES OF THROMBOSIS IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WITH ECULIZUMAB THERAPY

被引：0

作者：

Villegas, A. ^{[1
]}

Urbano, A. ^{[2
]}

Cuevas, M. ^{[3
]}

Roncero, M. ^{[4
]}

Ruiz, B. ^{[5
]}

Cordoba, R. ^{[6
]}

Fernandez, F. ^{[7
]}

Toscano, R. ^{[8
]}

Gaya, A. ^{[2
]}

Bermejo, A. ^{[9
]}

Mardones, L. ^{[10
]}

Loureiro, C. ^{[11
]}

Moreno, D. ^{[12
]}

Alcala, A. ^{[13
]}

De La Iglesia, S. ^{[14
]}

Calvillo, M. ^{[15
]}

Menayo, M. ^{[16
]}

Gonzalez, A. ^{[1
]}

Arrizabalaga, B. ^{[17
]}

机构：

[1] Hosp Clin San Carlos, Hematol, Madrid, Spain

[2] Hosp Clin Barcelona, Hematol, Barcelona, Spain

[3] Hosp Gen Burgos, Hematol, Burgos, Spain

[4] Hosp Virgen de la Salud, Hematol, Toledo, Spain

[5] Hosp Ciudad Real, Hematol, Ciudad Real, Spain

[6] Hosp Infanta Sofia, Hematol, Madrid, Spain

[7] Hosp Univ Insular Gran Canaria, Hematol, Las Palmas Gran Canaria, Spain

[8] Hosp 12 Octubre, Hematol, Madrid, Spain

[9] Hosp Fuenlabrada, Hematol, Madrid, Spain

[10] Hosp Mostoles, Hematol, Madrid, Spain

[11] Hosp Meixoeiro, Hematol, Vigo, Spain

[12] Hosp Infanta Margarita Cabra, Hematol, Cordoba, Spain

[13] Hosp Jaen, Hematol, Jaen, Spain

[14] Hosp Dr Negrin, Hematol, Las Palmas Gran Canaria, Spain

[15] Hosp Navarra, Hematol, Pamplona, Spain

[16] Hosp Basurto, Hematol, Bilbao, Spain

[17] Hosp Cruces Barakaldo, Hematol, Bilbao, Spain

来源：

HAEMATOLOGICA | 2013年 / 98卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

B1440

引用

页码：579 / 579

页数：1

共 50 条

[41] Severe Infection of Pseudomonas aeruginosa during Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria
Kawakami, Toru
Nakazawa, Hideyuki
Kurasawa, Yukifumi
Sakai, Hitoshi
Nishina, Sayaka
Senoo, Noriko
Senoo, Yasushi
Ishida, Fumihiro
INTERNAL MEDICINE, 2018, 57 (01) : 127 - 130
[42] The Importance of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: A Cohort Study
Yenerel, Mustafa Nuri
Erdem, Simge
Mastanzade, Metban
Nalcaci, Meliha
BLOOD, 2018, 132
[43] THERAPY FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
FREEMAN, H
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (23): : 1253 - 1254
[44] The complement inhibitor eculizumab improves anemia and reduces thrombosis in paroxysmal nocturnal hemoglobinuria (PNH) patients
Risitano, A. M.
Hillmen, P.
Young, N. S.
Muus, P.
Duehrsen, U.
Schubert, J.
Schrezenmeier, H.
Szer, J.
Brodsky, R. A.
Hill, A.
Socie, G.
Maciejewski, J. P.
Rollins, S. A.
Rother, R. P.
Bell, L.
Marinelli, F.
Antonioli, E.
Lori, A. P.
Rodeghiero, F.
Zanella, A.
Luzzatto, L.
Rotoli, B.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 88 - 88
[45] Safety and efficacy of eculizumab with concomitant erythropoietin therapy in patients with paroxysmal nocturnal hemoglobinuria (PNH)
Mojcik, C. F.
Young, N. S.
Luzzatto, L.
Socie, G.
Hillmen, P.
Brodsky, R. A.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[46] Fanconi syndrome and chronic kidney disease in paroxysmal nocturnal hemoglobinuria: effect of eculizumab therapy
Moumas, Eric
Bridoux, Frank
Leroy, Fannie
Belmouaz, Simohamed
Randriamalala, Edouard
Desport, Estelle
Dreyfus, Brigitte
Delbes, Sebastien
Quellard, Nathalie
Touchard, Guy
CLINICAL NEPHROLOGY, 2012, 78 (04) : 316 - 321
[47] Vaccination of patients with paroxysmal nocturnal hemoglobinuria under eculizumab treatment
Rodriguez-Garcia, Juan
Fernandez-Santos, Rafael
Antonio Garcia-Erce, Jose
MEDICINA CLINICA, 2012, 138 (14): : 640 - 641
[48] Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria
Schrezenmeier, Hubert
Hoechsmann, Britta
EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (01) : 7 - 16
[49] EFFICACY AND SAFETY OF ECULIZUMAB IN CHILDREN AND ADOLESCENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
Reiss, U.
Schwartz, J.
Puthenveetil, G.
Ogawa, M.
Ware, R.
HAEMATOLOGICA, 2012, 97 : 370 - 371
[50] Treatment of paroxysmal nocturnal hemoglobinuria in pregnancy with eculizumab: A case report
Fassett, Michael J.
Lopez, Adrian L. Hernandez
CASE REPORTS IN WOMENS HEALTH, 2021, 30

← 1 2 3 4 5 →